Current Clinical Trial Studies

We are currently offering clinical trials in the areas shown below. For more information, just click on the name of the study. All of our clinical trials follow FDA guidelines and adhere to the standards of good clinical practice. Leading national and international medical companies serve as sponsors for all of our trials. If you decide to take part in one of our studies, you can be assured that you will receive excellent care. That is our promise to you.

Diabetic Gastroparesis
Start Date: 10/1/2017
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 22 week, double blind, randomized study on the safety and efficacy of Relamorelin for the treatment of gastroparesis in patients with Type I or Type II Diabetes.

Disease Targeted:
Diabetic Gastroparesis

Objectives:
To evaluate the safety and efficacy of Relamorelin in patients with diabetic gastroparesis.

Type II Diabetes
Start Date: 10/1/2017
Enrollment Status: Closed

Ask A Question About This Study
Description:
A 29 week study on the effectiveness of bexagliflozin for subjects taking metformin.

Disease Targeted:
Type II Diabetes

Objectives:
To evaluate the efficacy and safety of bexagliflozin in subjects with Type II Diabetes who are not adequately controlled by metformin alone.

Low Testosterone
Start Date: 3/12/2018
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A phase IV, randomized, double-blind, placebo-controlled, multicenter study of topical testosterone medication in hypogonadal men with increased risk for cardiovascular disease.

Disease Targeted:
Low Testosterone

Objectives:
To compare the effect of testosterone replacement therapy and matching placebo on major cardiovascular events in men.

Adolescent Constipation
Start Date: 2/28/2020
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
A 20 week study to determine if linaclotide is safe and effective in the treatment of constipation in children age 6 to 17 years.

Disease Targeted:
Constipation

Objectives:
To evaluate the safety, tolerability and efficacy of linaclotide therapy compared to placebo in patients age 6 to 17 years with functional constipation.

Hypertension in Men with Low Testosterone
Start Date: 4/1/2020
Enrollment Status: Enrolling Now

Ask A Question About This Study
Enroll In This Trial
Description:
COMING SOON!!!! A 27 week study to assess the effect of AndroGel 1.62% on men over the age of 18 with a diagnosis of hypertension.

Disease Targeted:
Hypertension / Hypogonadism

Objectives:
The purpose of this phase IV, open-label, single-arm study to establish the non-inferiority with a margin of 3mmHg for change in 24 hour average systolic blood pressure from baseline to the end of treatment.